HIV-1 Nef-mediated downregulation of CD155 results in viral restriction by KIR2DL5+ NK cells

Standard

HIV-1 Nef-mediated downregulation of CD155 results in viral restriction by KIR2DL5+ NK cells. / Fittje, Pia; Hölzemer, Angelique; Garcia-Beltran, Wilfredo F; Vollmers, Sarah; Niehrs, Annika; Hagemann, Kerri; Martrus, Glòria; Körner, Christian; Kirchhoff, Frank; Sauter, Daniel; Altfeld, Marcus.

In: PLOS PATHOG, Vol. 18, No. 6, e1010572, 06.2022.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Fittje, P, Hölzemer, A, Garcia-Beltran, WF, Vollmers, S, Niehrs, A, Hagemann, K, Martrus, G, Körner, C, Kirchhoff, F, Sauter, D & Altfeld, M 2022, 'HIV-1 Nef-mediated downregulation of CD155 results in viral restriction by KIR2DL5+ NK cells', PLOS PATHOG, vol. 18, no. 6, e1010572. https://doi.org/10.1371/journal.ppat.1010572

APA

Fittje, P., Hölzemer, A., Garcia-Beltran, W. F., Vollmers, S., Niehrs, A., Hagemann, K., Martrus, G., Körner, C., Kirchhoff, F., Sauter, D., & Altfeld, M. (2022). HIV-1 Nef-mediated downregulation of CD155 results in viral restriction by KIR2DL5+ NK cells. PLOS PATHOG, 18(6), [e1010572]. https://doi.org/10.1371/journal.ppat.1010572

Vancouver

Bibtex

@article{f4f1260518f444e3aadab89c1db38b16,
title = "HIV-1 Nef-mediated downregulation of CD155 results in viral restriction by KIR2DL5+ NK cells",
abstract = "Antiviral NK cell activity is regulated through the interaction of activating and inhibitory NK cell receptors with their ligands on infected cells. HLA class I molecules serve as ligands for most killer cell immunoglobulin-like receptors (KIRs), but no HLA class I ligands for the inhibitory NK cell receptor KIR2DL5 have been identified to date. Using a NK cell receptor/ligand screening approach, we observed no strong binding of KIR2DL5 to HLA class I or class II molecules, but confirmed that KIR2DL5 binds to the poliovirus receptor (PVR, CD155). Functional studies using primary human NK cells revealed a significantly decreased degranulation of KIR2DL5+ NK cells in response to CD155-expressing target cells. We subsequently investigated the role of KIR2DL5/CD155 interactions in HIV-1 infection, and showed that multiple HIV-1 strains significantly decreased CD155 expression levels on HIV-1-infected primary human CD4+ T cells via a Nef-dependent mechanism. Co-culture of NK cells with HIV-1-infected CD4+ T cells revealed enhanced anti-viral activity of KIR2DL5+ NK cells against wild-type versus Nef-deficient viruses, indicating that HIV-1-mediated downregulation of CD155 renders infected cells more susceptible to recognition by KIR2DL5+ NK cells. These data show that CD155 suppresses the antiviral activity of KIR2DL5+ NK cells and is downmodulated by HIV-1 Nef protein as potential trade-off counteracting activating NK cell ligands, demonstrating the ability of NK cells to counteract immune escape mechanisms employed by HIV-1.",
keywords = "Antiviral Agents/metabolism, Down-Regulation, HIV Infections, HIV Seropositivity, HIV-1, Humans, Killer Cells, Natural, Ligands, Receptors, Natural Killer Cell/metabolism, Receptors, Virus, nef Gene Products, Human Immunodeficiency Virus/genetics",
author = "Pia Fittje and Angelique H{\"o}lzemer and Garcia-Beltran, {Wilfredo F} and Sarah Vollmers and Annika Niehrs and Kerri Hagemann and Gl{\`o}ria Martrus and Christian K{\"o}rner and Frank Kirchhoff and Daniel Sauter and Marcus Altfeld",
year = "2022",
month = jun,
doi = "10.1371/journal.ppat.1010572",
language = "English",
volume = "18",
journal = "PLOS PATHOG",
issn = "1553-7366",
publisher = "Public Library of Science",
number = "6",

}

RIS

TY - JOUR

T1 - HIV-1 Nef-mediated downregulation of CD155 results in viral restriction by KIR2DL5+ NK cells

AU - Fittje, Pia

AU - Hölzemer, Angelique

AU - Garcia-Beltran, Wilfredo F

AU - Vollmers, Sarah

AU - Niehrs, Annika

AU - Hagemann, Kerri

AU - Martrus, Glòria

AU - Körner, Christian

AU - Kirchhoff, Frank

AU - Sauter, Daniel

AU - Altfeld, Marcus

PY - 2022/6

Y1 - 2022/6

N2 - Antiviral NK cell activity is regulated through the interaction of activating and inhibitory NK cell receptors with their ligands on infected cells. HLA class I molecules serve as ligands for most killer cell immunoglobulin-like receptors (KIRs), but no HLA class I ligands for the inhibitory NK cell receptor KIR2DL5 have been identified to date. Using a NK cell receptor/ligand screening approach, we observed no strong binding of KIR2DL5 to HLA class I or class II molecules, but confirmed that KIR2DL5 binds to the poliovirus receptor (PVR, CD155). Functional studies using primary human NK cells revealed a significantly decreased degranulation of KIR2DL5+ NK cells in response to CD155-expressing target cells. We subsequently investigated the role of KIR2DL5/CD155 interactions in HIV-1 infection, and showed that multiple HIV-1 strains significantly decreased CD155 expression levels on HIV-1-infected primary human CD4+ T cells via a Nef-dependent mechanism. Co-culture of NK cells with HIV-1-infected CD4+ T cells revealed enhanced anti-viral activity of KIR2DL5+ NK cells against wild-type versus Nef-deficient viruses, indicating that HIV-1-mediated downregulation of CD155 renders infected cells more susceptible to recognition by KIR2DL5+ NK cells. These data show that CD155 suppresses the antiviral activity of KIR2DL5+ NK cells and is downmodulated by HIV-1 Nef protein as potential trade-off counteracting activating NK cell ligands, demonstrating the ability of NK cells to counteract immune escape mechanisms employed by HIV-1.

AB - Antiviral NK cell activity is regulated through the interaction of activating and inhibitory NK cell receptors with their ligands on infected cells. HLA class I molecules serve as ligands for most killer cell immunoglobulin-like receptors (KIRs), but no HLA class I ligands for the inhibitory NK cell receptor KIR2DL5 have been identified to date. Using a NK cell receptor/ligand screening approach, we observed no strong binding of KIR2DL5 to HLA class I or class II molecules, but confirmed that KIR2DL5 binds to the poliovirus receptor (PVR, CD155). Functional studies using primary human NK cells revealed a significantly decreased degranulation of KIR2DL5+ NK cells in response to CD155-expressing target cells. We subsequently investigated the role of KIR2DL5/CD155 interactions in HIV-1 infection, and showed that multiple HIV-1 strains significantly decreased CD155 expression levels on HIV-1-infected primary human CD4+ T cells via a Nef-dependent mechanism. Co-culture of NK cells with HIV-1-infected CD4+ T cells revealed enhanced anti-viral activity of KIR2DL5+ NK cells against wild-type versus Nef-deficient viruses, indicating that HIV-1-mediated downregulation of CD155 renders infected cells more susceptible to recognition by KIR2DL5+ NK cells. These data show that CD155 suppresses the antiviral activity of KIR2DL5+ NK cells and is downmodulated by HIV-1 Nef protein as potential trade-off counteracting activating NK cell ligands, demonstrating the ability of NK cells to counteract immune escape mechanisms employed by HIV-1.

KW - Antiviral Agents/metabolism

KW - Down-Regulation

KW - HIV Infections

KW - HIV Seropositivity

KW - HIV-1

KW - Humans

KW - Killer Cells, Natural

KW - Ligands

KW - Receptors, Natural Killer Cell/metabolism

KW - Receptors, Virus

KW - nef Gene Products, Human Immunodeficiency Virus/genetics

U2 - 10.1371/journal.ppat.1010572

DO - 10.1371/journal.ppat.1010572

M3 - SCORING: Journal article

C2 - 35749424

VL - 18

JO - PLOS PATHOG

JF - PLOS PATHOG

SN - 1553-7366

IS - 6

M1 - e1010572

ER -